Medicine information
Uses & overview
Pafagold 5 is a tablet in the Diabetes category, manufactured by Steris Healthcare Pvt. Ltd. Each tablet contains Dapagliflozin 5 mg, which the catalogue describes as a Sodium-Glucose Cotransporter-2 (SGLT2) inhibitor and an oral anti-diabetic medication. Product details: - Brand name: Pafagold 5 - Composition: Dapagliflozin 5 mg - Dosage form: Tablet - Manufacturer: Steris Healthcare Pvt. Ltd. - Category: Diabetes - Prescription status: Schedule H The catalogue describes the medicine as working through an insulin-independent mechanism, helping the body remove excess glucose through urine. The catalogue also lists use in adults with type 2 diabetes mellitus as an adjunct to diet and exercise, and mentions heart failure hospitalization risk and chronic kidney disease in its product text. Pafagold 5 is a Schedule H drug, so it should be purchased and used only on the prescription of a registered medical practitioner. Dose, suitability and duration of use should be determined by a doctor. Read the packaging and patient information leaflet before use.
How to use
Take 1 tablet of PAFAGOLD 5 once daily in the morning, with or without food, or as prescribed by your physician. Swallow the tablet whole with a glass of water. Stay well-hydrated throughout the day to support kidney function and minimize dehydration risks.
Storage
Store in a cool, dry place away from direct sunlight, heat, and moisture. Store at a controlled room temperature below 30°C. Keep out of reach and sight of children.





